Other
Intensive Care Unit
1
Pipeline Programs↗
9
Active Trials↗
2
Companies Involved↗
Intensive Care Unit is an early-stage landscape with 1 program across 2 companies. The most active players are Pfizer, GSK.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
82
clinical trials
Completed48 · 59%
Unknown status17 · 21%
Terminated6 · 7%
Recruiting6 · 7%
Not yet recruiting3 · 4%
Withdrawn2 · 2%
Clinical Trials
Trial Activity
82 trials
Cenobamate in the Intensive Care Unit
Not yet recruiting·—·Phase 1·NCT06352723·10 enrolled
Nicotine Replacement Therapy in the Intensive Care Unit
Completed·—·Phase 4·NCT01362959·47 enrolled
Page 1 of 6
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)